DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Equity Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
A••••• P•••••••
Hybrid managerClassification probableunsized· Paris
••• Locked
As of · identity and classification; each section below carries its own date
- Regulatory AUM
- Not applicable
- PE fund assets
- Not applicable
- PE funds
- Not applicable
- Investments held
- 2 of 288
- Deals, last 12 months
- 0
DFX transaction tape
DFX transaction tape
As of · identity and classification; each section below carries its own date
What we can say about this record
We hold this organization as an identified record, with no Form ADV on record and 13 observations. No recent transaction, no vehicle in market and no stated mandate is on this record, so there is nothing here to act on today. It is still the right record for resolving this name, its filings and its relationships.
Classification
How this organization is classified, and on what basisHybrid manager · 2 in historyShowHide
- Class
- Hybrid managerprobable, confidence 65%
- Basis
- R4: Private Equity Funds are 0 of 1 distinct vehicles; hedge, securitized or liquidity vehicles 0
- Size band
- unsizeddefined by: no Private Equity Fund GAV on a filing from 2021 or later
Classification history (2)
- Sep 16, 2026Hybrid manager (probable, 65%, cls-pe-2)R4: Private Equity Funds are 0 of 1 distinct vehicles; hedge, securitized or liquidity vehicles 0
- Sep 16, 2026Hybrid manager (probable, 65%, cls-pe-2)R4: Private Equity Funds are 0 of 1 distinct vehicles; hedge, securitized or liquidity vehicles 0
Regulatory footprint (Form ADV)
- Adviser type
- unknown
- Form ADV filings
- unknown
- RAUM
- unknownregulatory assets under management of the adviser; not dry powder, not a fund size
- PE funds, latest filing
- unknown
- PE fund GAV, latest filing
- unknownreported gross assets (Form ADV), not fund size
- All private fund GAV
- unknownevery private fund type, latest filing
- 2024 PE fund GAV
- unknownsum over funds typed Private Equity Fund with a 2024 or later as-of date
- PE share of funds, lifetime
- unknown
- Employees
- unknown
Stated criteria beside observed behaviour
288 observed deals
Stated by the firm
- Sectors
- not stated or not yet read
- Geography
- not stated or not yet read
- Revenue
- not stated or not yet read
- EBITDA
- not stated or not yet read
- Enterprise value
- not stated or not yet read
- Equity check
- not stated or not yet read
- Control
- not stated or not yet read
- Thesis
- ••• Locked
Observed from deals on record
- roles
- unknown 286, platform 2
- period
- to 2025-01-20, from 2024-11-14, undated holdings 286, dated observations 4
- window
- last 2025-01-20, first 2024-11-14
- control
- control 2, unknown 286
- companies
- 288
- geography
- count 1, share 0.003, value CA
- investments
- 288
- seller kinds
- transactions
- 2
- cadence by year
- 2024 platforms 1, 2025 platforms 1
- platform add on
- add ons 0, platforms 2, add ons per platform unknown
- sector known for
- 58
- disclosed value usd
- n 0
- sector distribution
- count 11, share 0.038, value industrial manufacturing, examples OneXillium, Fila, PM Studio, Marie-Laure PLV, count 11, share 0.038, value life sciences, examples Targed, Kestra Medical Technologies, Spiro Medical Inc., FH Ortho, count 7, share 0.024, value software, examples A2IA, OCTIME, Travelsoft, DP Logiciels, count 7, share 0.024, value healthcare services, examples PegaOne, Nouscom, Company Confidential, In’Tech Medical, count 6, share 0.021, value energy, examples Terr.A, Skysun, Ensol, Kyotherm, count 4, share 0.014, value business services, examples Spartes, Plasseraud IP, Xelians, Jaws Group, count 4, share 0.014, value media telecom, examples Telecom Design, Prozone, Oberthur, Intescia, count 3, share 0.01, value specialty distribution, examples Exclusive Group, Groupe Gosto, Itesa
- holding period years
- n 0
- repeat counterparties
- subsector distribution
- count 8, share 0.028, value miscellaneous manufacturing, examples Fila, PM Studio, Marie-Laure PLV, ACE, count 7, share 0.024, value software, examples A2IA, OCTIME, Travelsoft, DP Logiciels, count 6, share 0.021, value energy, examples Terr.A, Skysun, Ensol, Kyotherm, count 6, share 0.021, value outpatient specialty clinics, examples PegaOne, Nouscom, In’Tech Medical, Rivermark Medical, count 6, share 0.021, value life sciences, examples Targed, Adcytherix, Alveus Therapeutics, Dualyx, count 5, share 0.017, value medical devices, examples Kestra Medical Technologies, Spiro Medical Inc., FH Ortho, Autonomic Technologies, count 4, share 0.014, value media telecom, examples Telecom Design, Prozone, Oberthur, Intescia, count 3, share 0.01, value misc durable wholesale, examples Exclusive Group, Groupe Gosto, Itesa
288 companies on the graph (2 transactions); most in industrial manufacturing (11); 2 platforms and 0 add-ons; observed 2024 to 2025
Funds
0 on record
No fund collected for this firm yet. Funds arrive from Form ADV Schedule D 7.B.(1) and Form D filings.
Team
20 current, 0 former
Partner (11)
- A••••• R•••••• · I•••••ment Manager · start date unknown I•••••ment organization websites (team, portfolio, strategy, criteria, news)
- A••••• C••••• · I•••••ment Manager · start date unknown I•••••ment organization websites (team, portfolio, strategy, criteria, news)
- A•••••• L• B•••••••• · Partner · start date unknown I•••••ment organization websites (team, portfolio, strategy, criteria, news)
- E••••• P••• · I•••••ment Manager · start date unknown I•••••ment organization websites (team, portfolio, strategy, criteria, news)
- F•••••••• G•••••• · Partner · start date unknown Press release wires (PR Newswire, G••••Newswire, Business Wire public pages and RSS)
- F•••••••• G•••••• · Partner · start date unknown I•••••ment organization websites (team, portfolio, strategy, criteria, news)
- L•••••• T••••••• · Partner · start date unknown I•••••ment organization websites (team, portfolio, strategy, criteria, news)
- P••••••••• G••••• · I•••••ment Manager · start date unknown I•••••ment organization websites (team, portfolio, strategy, criteria, news)
- P••••••••• P•••••• · Partner · start date unknown I•••••ment organization websites (team, portfolio, strategy, criteria, news)
- S•••••• C•••••••• · Partner · start date unknown I•••••ment organization websites (team, portfolio, strategy, criteria, news)
- V•••••• B•••••••• · Partner · start date unknown I•••••ment organization websites (team, portfolio, strategy, criteria, news)
Principal (4)
- C•••• C•••••••• · I•••••ment Director · start date unknown I•••••ment organization websites (team, portfolio, strategy, criteria, news)
- D•••••••• d• V••••• · Director · start date unknown I•••••ment organization websites (team, portfolio, strategy, criteria, news)
- E•••••• R•••••••• · I•••••ment Director · start date unknown I•••••ment organization websites (team, portfolio, strategy, criteria, news)
- G•••••• B•••• · Director · start date unknown I•••••ment organization websites (team, portfolio, strategy, criteria, news)
Analyst (1)
- C••••••• P•••••• · Analyst · start date unknown I•••••ment organization websites (team, portfolio, strategy, criteria, news)
Platform (1)
- V•••••• V•••••• · Team Assistant · start date unknown I•••••ment organization websites (team, portfolio, strategy, criteria, news)
Other (3)
- H••• V•• d• V•••• · Senior Advisor Belgium · start date unknown I•••••ment organization websites (team, portfolio, strategy, criteria, news)
- I•••••• M••••• M••••••• · Senior Advisor Spain · start date unknown I•••••ment organization websites (team, portfolio, strategy, criteria, news)
- M••••••• B••••••••• · Senior Advisor Italy · start date unknown I•••••ment organization websites (team, portfolio, strategy, criteria, news)
Portfolio
288 relationships, 2 platforms, 0 add-ons
Showing 100 of 288 investments. Show all 288. The rest are held, not withheld: the full set is on that URL and in the export.
Transactions
9 on record
| Date | Type | Target | This firm’s role | Source |
|---|---|---|---|---|
| Feb 26, 2026 | Exit to a strategic buyer | H••••••• | Seller (confirmed) | a•••••••••.com |
| Oct 23, 2025 | Exit to a strategic buyer | A•••• O•••• | Seller (confirmed) | a•••••••••.com |
| Mar 3, 2025 | Exit to a strategic buyer | S•••••• | Seller (confirmed) | a•••••••••.com |
| Jan 20, 2025 | Platform acquisition | A••••• | Sponsor (confirmed) | a•••••••••.com |
| Nov 14, 2024 | Platform acquisition | H•••• F•••••• | Sponsor (confirmed) | a•••••••••.com |
| Mar 14, 2024 | Exit to a strategic buyer | A••••• P••••• | Seller (confirmed) | a•••••••••.com |
| Jan 10, 2023 | Exit to a strategic buyer | S•••••• | Seller (confirmed) | a•••••••••.com |
| Nov 22, 2021 | Exit to a strategic buyer | S•••••• | Seller (confirmed) | a•••••••••.com |
| Jan 12, 2021 | Exit to a strategic buyer | P••••••• 1••• | Seller (confirmed) | a•••••••••.com |
Placement agents, lenders, advisers and co-investors
0 relationships
No counterparty collected yet. These are counted from transactions that name both this firm and the other party, and from placement agents on this firm’s funds.
LP commitments
0 disclosed
No LP commitment collected yet. An LP edge needs a public disclosure with a quote, such as a pension plan’s report or an announcement naming the LP.
Events
60 most recent
- Sep 15, 2026A••••• P••••••• reports 7 Private Equity Fund(s) on its first Form ADV (ERA - Active); new on IAPD 2026-09-16New pe adviser on rosterFactSEC IAPD daily compilation report (registered + exempt reporting advisers) and Form ADV Part 1 PDFs
- Jun 29, 202629.06.2026 - andera Life Sciences - Press releases A••••• P••••••• joins the E••••••• Life Sciences Coalition (ELSC) with the aim to support the mobili…
- May 11, 202611.05.2026 - andera I•••• - Press releases A••••• I•••• sells its stake in Nostrum Group to IREN, listed on the NASDAQ.
- Apr 9, 202609.04.2026 - andera MidCap - Press releases T••••••••• acquires EIS Wire & Cable, expanding its presence in the USA within the industrial a…
- Apr 7, 202607.04.2026 - andera Life Sciences - Press releases A••••• P••••••• portfolio company, T••••••, acquired by Gilead, adding a potentially best-in-class a…
- Mar 5, 202605.03.2026 - andera Acto - Press releases A••••• P••••••• accelerates its development in Spain and appoints Joaquín G•••••• for its sponsorles…
- Feb 26, 2026- andera Acto - Press releases S4BT acquires H••••••• to become the ultimate powerhouse in global business travel.
- Feb 26, 202626.02.2026 - andera Acto - Press releases S4BT acquires H••••••• to become the ultimate powerhouse in global business travel.
- Feb 19, 202619.02.2026 - andera Acto - Press releases A••••• Acto invests in the Austrian company e••••• C••• G••••
- Feb 9, 202609.02.2026 - andera Life Sciences - Press releases Agomab, portfolio company of A••••• P•••••••, completes successful Nasdaq listing with $200 million…
- Oct 23, 2025- andera MidCap - Press releases A••••• P••••••• invests in A•••• O••••, leading player in premium orthopedic implants and bioresorba…
- Oct 23, 202523.10.2025 - andera MidCap - Press releases A••••• P••••••• invests in A•••• O••••, leading player in premium orthopedic implants and bioresorba…
- Oct 22, 202522.10.2025 - andera Life Sciences - Press releases Ipsen to acquire ImCheck T•••••••••, in A••••• P•••••••’ portfolio, expanding its leadership in on…
- Oct 16, 202516.10.2025 - andera Life Sciences - Press releases A••••• P••••••• co-leads €105 million Series A round for A•••••••••, its first investment from the B…
- May 22, 202522.05.2025 - andera MidCap - Press releases A••••• P••••••• announces the signing of an exclusive agreement with Ardian to acquire a majority st…
- Mar 3, 2025- andera Life Sciences - Press releases Boston Scientific announces agreement to acquire S•••••• Ltd.
- Mar 3, 202503.03.2025 - andera Life Sciences - Press releases Boston Scientific announces agreement to acquire S•••••• Ltd.
- Feb 3, 202503.02.2025 - andera Acto - Press releases A••••• P••••••• invests together with founder and historical shareholders of C•• G••••
- Jan 20, 2025- andera MidCap - Press releases A••••• joins forces with A••••• P••••••• to accelerate its development alongside the management team…Platform investmentFactA•••••Press release wires (PR Newswire, G••••Newswire, Business Wire public pages and RSS)
- Jan 20, 202520.01.2025 - andera MidCap - Press releases A••••• joins forces with A••••• P••••••• to accelerate its development alongside the management team…
- Dec 12, 202412.12.2024 - A••••• P••••••• - Press releases New York Life I•••••ments and its E••••••• Affiliate, Candriam, Announce Strategic Partnership with…
- Nov 14, 2024- andera MidCap - Press releases H•••• F•••••• joins forces with A••••• P••••••• to accelerate the development of its fine arts logis…
- Nov 14, 202414.11.2024 - andera MidCap - Press releases H•••• F•••••• joins forces with A••••• P••••••• to accelerate the development of its fine arts logis…
- Jul 25, 202425.07.2024 - andera Life Sciences - Press releases A••••• P•••••••’ portfolio company J•••••••• T•••nology acquired by Edwards Lifesciences
- Jul 15, 202415.07.2024 - andera Life Sciences - Press releases A••••• P•••••••’ portfolio company A••••• P••••• completes acquisition by AstraZeneca
- Jun 27, 202427.06.2024 - andera Expansion/C••••••••• - Press releases S••••••• G•••• takes on a E••••••• dimension with the acquisition of German manufacturer Luxamed
- Mar 14, 2024- andera Life Sciences - Press releases A••••• P•••••, an A••••• P•••••••’ portfolio company, announces its sale to AstraZeneca
- Mar 14, 202414.03.2024 - andera Life Sciences - Press releases A••••• P•••••, an A••••• P•••••••’ portfolio company, announces its sale to AstraZeneca
- Mar 14, 202414.03.2024 - andera Life Sciences - Press releases A••••• P•••••••’ portfolio company T•••••• closes upsized €128 Million Series B2 to accelerate the d…
- Feb 12, 202412.02.2024 - A••••• P••••••• - Press releases 2023 Report – After a record year of investments and exits, A••••• P••••••• sets a target of 7…
- Dec 14, 202314.12.2023 - andera Acto - Press releases The E••• Group joins forces with the Nodarius Group, which includes the Altogen brand, to strengthen…
- Nov 13, 202313.11.2023 - andera Acto - Press releases A••••• P••••••• joins forces with Founders of G•••• Group in providing support in their internationa…
- Oct 10, 202310.10.2023 - andera Expansion/C••••••••• - Press releases E••• L•••••••• acquires Dutch company AVB V•••alingen
- Oct 4, 202304.10.2023 - andera Acto - Press releases A••••• P••••••• completes full exit from T••••••••• Group and hands over to CAPZA
- Jul 6, 202306.07.2023 - andera MidCap - Press releases PAI Partners to acquire majority stake in I•••• G••••
- Jul 4, 202304.07.2023 - andera Expansion/C••••••••• - Press releases E••• L•••••••• completes acquisition of German group Lingua-World GmbH
- May 10, 202310.05.2023 - A••••• P••••••• - Press releases A••••• P••••••• appoints Stefan Keitel Senior Advisor DACH region further strengthening its presence…
- Apr 25, 202325.04.2023 - andera Acto - Press releases O••••••••• group partners with A••••• Acto to support them in their next development cycle
- Apr 5, 202305.04.2023 - andera Acto - Press releases B•• G•••• (A••••• Acto) expands in Italy, through acquisition of Capanna
- Mar 3, 202303.03.2023 - andera Life Sciences - Press releases F••••••• T••••••••• and Dynacure Announce Merger to Create Leading RNA T••••••••• Company Focuse…
- Mar 1, 202301.03.2023 - andera Acto - Press releases R•••••• partners with A••••• Acto to support them in their next development cycle
- Feb 13, 202313.02.2023 - andera Life Sciences - Press releases A••••• P••••••• Portfolio Company M•••••••• T••••••••• Successfully Completes Upsized $192 Million…
- Jan 10, 2023- andera Life Sciences - Press releases A••••• P••••••• invests in S••••••, a medtech company developing a promising device for the treatmen…
- Jan 10, 202310.01.2023 - andera Life Sciences - Press releases A••••• P••••••• invests in S••••••, a medtech company developing a promising device for the treatmen…
- Oct 25, 202225.10.2022 - andera MidCap - Press releases K•••• G•••• acquires Isoli S.p.A.
- Oct 13, 202213.10.2022 - andera MidCap - Press releases A••••• P••••••• invests in a high-performance detection solutions company S•••••••••
- Oct 3, 202203.10.2022 - andera Life Sciences - Press releases Alexion, AstraZeneca Rare Disease to Acquire L•••••••® T••••••••• to Accelerate Growth in Genomic…
- Sep 16, 202216.09.2022 - andera Life Sciences - Press releases J•••••••• Completes Enrollment in the ALIGN-ARIDE Clinical Trial
- Jun 13, 202213.06.2022 - andera Life Sciences - Press releases ImCheck Closes Upsized EUR 96 Million (USD 103 Million) F••••••ng to Advance Clinical Validation of…
- May 13, 2022- andera MidCap - Press releases A••••• P••••••• announces the intermediate closing of its new fund A••••• MidCap 5 at €450m
- May 13, 202213.05.2022 - andera MidCap - Press releases A••••• P••••••• announces the intermediate closing of its new fund A••••• MidCap 5 at €450m
- Apr 1, 202201.04.2022 - andera Co-I••••• - Press releases A••••• P••••••• and Compagnie Lebon launch a co-investment activity
- Mar 31, 202231.03.2022 - A••••• P••••••• - Press releases A••••• P••••••• announces two promotions to Partner and several appointments to strengthen its teams
- Feb 3, 202203.02.2022 - andera I•••• - Press releases A••••• P••••••• invests in green renewable hydrogen production company L••••
- Jan 19, 202219.01.2022 - andera Life Sciences - Press releases J•••••••• Announces Strategic I•••••ment and Licensing Agreement with Peijia M•••••• Limited
- Nov 22, 2021- andera Life Sciences - Press releases Vifor P••••• to acquire S•••••• to further strengthen late-stage pipeline in nephrology
- Nov 22, 202122.11.2021 - andera Life Sciences - Press releases Vifor P••••• to acquire S•••••• to further strengthen late-stage pipeline in nephrology
- Nov 15, 202115.11.2021 - andera Acto - Press releases A••••• P••••••• supports the Founder of ENACO Group in the acquisition of its entire share capital a…
- Oct 28, 202128.10.2021 - andera Life Sciences - Press releases Agomab T••••••••• to Acquire Origo Biopharma
- Sep 8, 202108.09.2021 - A••••• P••••••• - Press releases A••••• P••••••• strengthens its investment teams and reaffirms its growth ambition